Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
8,705 USD | +8,81 % |
|
+36,32 % | -41,77 % |
Métier
Nombre d'employés: 74
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jaume Pons
FOU | Founder | 58 | 01/04/15 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 01/04/20 |
Peter García
DFI | Director of Finance/CFO | 62 | 01/01/20 |
Chief Tech/Sci/R&D Officer | - | 01/11/21 | |
Sophia Randolph
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/06/16 |
Michael Chang
COO | Chief Operating Officer | - | 01/03/15 |
Shelly Pinto
AUD | Comptroller/Controller/Auditor | 48 | 03/05/21 |
Hong I. Wan
PRN | Corporate Officer/Principal | - | 01/04/15 |
Hank Stern
PRN | Corporate Officer/Principal | - | 01/01/15 |
Chris Byrd
LAW | General Counsel | - | 01/05/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 28/11/22 |
Corey Goodman
CHM | Chairman | 72 | 01/03/15 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 01/04/20 |
Rekha Hemrajani
BRD | Director/Board Member | 54 | 01/04/20 |
Jaume Pons
FOU | Founder | 58 | 01/04/15 |
Sophia Randolph
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/06/16 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 52 100 107 | 41 342 157 ( 79,35 %) | 0 | 79,35 % |
Coordonnées société
![Adresse ALX Oncology Holdings Inc.(ALXO)](https://cdn.zonebourse.com/static/address/109818466.png)
Secteur
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-46,27 % | 417 M | |
+20,63 % | 127 Md | |
+24,75 % | 27,67 Md | |
-20,17 % | 20,33 Md | |
-16,50 % | 16,79 Md | |
-18,07 % | 15,63 Md | |
-47,70 % | 14,65 Md | |
+11,92 % | 14,84 Md | |
+58,32 % | 14,43 Md | |
+149,98 % | 12,49 Md |
- Bourse
- Actions
- Action ALXO
- Société ALX Oncology Holdings Inc.